| Differential macrophage programming in the tumor microenvironment B Ruffell, NI Affara, LM Coussens Trends in immunology 33 (3), 119-126, 2012 | 962 | 2012 |
| FcRγ activation regulates inflammation-associated squamous carcinogenesis P Andreu, M Johansson, NI Affara, F Pucci, T Tan, S Junankar, L Korets, ... Cancer cell 17 (2), 121-134, 2010 | 622 | 2010 |
| Bruton tyrosine kinase–dependent immune cell cross-talk drives pancreas cancer AJ Gunderson, MM Kaneda, T Tsujikawa, AV Nguyen, NI Affara, B Ruffell, ... Cancer discovery 6 (3), 270-285, 2016 | 455 | 2016 |
| Lymphocytes in cancer development: polarization towards pro-tumor immunity B Ruffell, DG DeNardo, NI Affara, LM Coussens Cytokine & growth factor reviews 21 (1), 3-10, 2010 | 317 | 2010 |
| B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas NI Affara, B Ruffell, TR Medler, AJ Gunderson, M Johansson, S Bornstein, ... Cancer cell 25 (6), 809-821, 2014 | 302 | 2014 |
| Ibrutinib exerts potent antifibrotic and antitumor activities in mouse models of pancreatic adenocarcinoma D Massó-Vallés, T Jauset, E Serrano, NM Sodir, K Pedersen, NI Affara, ... Cancer research 75 (8), 1675-1681, 2015 | 117 | 2015 |
| Stromal regulation of vessel stability by MMP14 and TGFβ NE Sounni, K Dehne, L Van Kempen, M Egeblad, NI Affara, I Cuevas, ... Disease models & mechanisms 3 (5-6), 317-332, 2010 | 111 | 2010 |
| Cathepsin C is a tissue-specific regulator of squamous carcinogenesis B Ruffell, NI Affara, L Cottone, S Junankar, M Johansson, DG DeNardo, ... Genes & development 27 (19), 2086-2098, 2013 | 98 | 2013 |
| Delineating protease functions during cancer development NI Affara, P Andreu, LM Coussens Proteases and Cancer: Methods and Protocols, 1-32, 2009 | 80 | 2009 |
| IKKα at the crossroads of inflammation and metastasis NI Affara, LM Coussens Cell 129 (1), 25-26, 2007 | 62 | 2007 |
| Vascular endothelial growth factor as a survival factor in tumor-associated angiogenesis NI Affara, FM Robertson in vivo 18 (5), 525-542, 2004 | 39 | 2004 |
| Activation of Akt and mTOR in CD34+/K15+ keratinocyte stem cells and skin tumors during multi-stage mouse skin carcinogenesis NI Affara, CS Trempus, BL Schanbacher, P Pei, SR Mallery, JA Bauer, ... Anticancer research 26 (4B), 2805-2820, 2006 | 34 | 2006 |
| Activated Akt-1 in specific cell populations during multi-stage skin carcinogenesis NI Affara, BL Schanbacher, MJ Mihm, AC Cook, P Pei, SR Mallery, ... Anticancer research 24 (5A), 2773-2782, 2004 | 9 | 2004 |
| Proteolytic pathways: intersecting cascades in cancer development NI Affara, LM Coussens The Cancer Degradome: Proteases and Cancer Biology, 157-182, 2008 | 5 | 2008 |
| Pharmacological inhibition of Bruton's Tyrosine Kinase (BTK) as a therapy for insulinoma and pancreatic ductal adenocarcinoma. D Massó-Vallés, E Serrano, JR Whitfield, JJ Buggy, NM Sodir, NI Affara, ... Cancer Research 73 (8_Supplement), 4956-4956, 2013 | 1 | 2013 |
| NOS3 Exon7 (Glu298Asp) polymorphism regulates VEGF-induced endothelial cell wound closure in vitro: response to treatment with VEGF205* isoform MS Joshi, BL Schanbacher, NI Affara, FM Robertson, JA Bauer Circulation 110 (17), 245-245, 2004 | 1 | 2004 |
| The cellular triumvirate: fibroblasts entangled in the crosstalk between cancer cells and immune cells A Fergatova, NI Affara Frontiers in Immunology 14, 1337333, 2024 | | 2024 |
| Correction: Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer (vol 6, pg 270, 2016) AJ Gunderson, MM Kaneda, T Tsujikawa, A Nguyen, N Affara, B Ruffell CANCER DISCOVERY 6 (7), 802-802, 2016 | | 2016 |
| Ibrutinib exerts potent antifibrotic activity in a mouse model of pancreatic adenocarcinoma D Massó-Vallés, T Jauset, E Serrano, NM Sodir, K Pedersen, NI Affara, ... Cancer Research 75 (15_Supplement), 396-396, 2015 | | 2015 |
| CD20 as a target for therapy in solid tumors NI Affara, B Ruffell, M Johansson, K Fujikawa, E Bergsland, DG DeNardo, ... Cancer Research 72 (8_Supplement), 4391-4391, 2012 | | 2012 |
